Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2025
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals held its 46th Annual General Meeting on September 24, 2025, via Video Conferencing, from 3:30 PM to 4:23 PM, chaired by Non-Executive Chairman Mr. Harsha Raghavan. The meeting covered adoption of audited financial statements for FY ending March 31, 2025, declaration of dividend for FY25, and reappointment of Managing Director Mr. Manish Gupta (who retires by rotation). Members also approved ratification of remuneration for Cost Auditors Kirit Mehta & Co. for FY26, and a special resolution on revising the Managing Director's remuneration. Additionally, an appointment of a Secretarial Auditor was tabled. The Chairman and MD briefed members on company operations, achievements, and future outlook, and responded to shareholder queries. E-voting results will be announced within 2 working days by the scrutinizer Mr. Ayush Khandelwal.
Routine AGM proceedings with a key highlight being the proposed revision in Managing Director's remuneration (passed as a special resolution) and FY25 dividend declaration. Voting results, expected within 2 working days, will confirm shareholder approval and could influence sentiment around the stock.